| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Revenue | $15.3M | +131.9% |
| Cost of Revenue | $19.5M | +83.0% |
| Gross Profit | -$4.1M | -2.6% |
| R&D Expense | $35.7M | +48.3% |
| SG&A Expense | $20.7M | +55.9% |
| Operating Income | -$60.6M | -46.3% |
| Income Tax | -$1.8M | — |
| Net Income | -$59.0M | -33.7% |
| EPS (Basic) | -$1.09 | -6.9% |
| EPS (Diluted) | -$1.09 | -6.9% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $80.5M | -8.9% |
| Accounts Receivable | $3.8M | +224.2% |
| Inventory | $4.1M | +194.5% |
| Current Assets | $91.7M | -1.6% |
| Total Assets | $161.3M | +29.1% |
| Current Liabilities | $12.7M | +74.2% |
| Total Liabilities | $57.9M | +663.6% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.2M | -53.9% |
| Investing Cash Flow | -$34.9M | -179.7% |
| Financing Cash Flow | $72.3M | -15.7% |
| Stockholders' Equity |
| $103.4M |
| -11.9% |